✦ LIBER ✦

Botulinum toxin type A therapy during pregnancy

✍ Scribed by Cynthia L. Bodkin; Kenneth B. Maurer; Zbigniew K. Wszolek

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 43 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin type A therapy during pr

Botulinum toxin type A therapy during pregnancy

✍ William J. Newman; Thomas L. Davis; Bismal B. Padaliya; Cassondra D. Covington; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

## Abstract Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full‐term pregnancies while receiving r

Erratum: Botulinum toxin type a therapy

Erratum: Botulinum toxin type a therapy during pregnancy. Mov Disord 2004;19(11):1384–1385

✍ William J. Newman; Thomas L. Davis; Bimal B. Padaliya; Cassondra D. Covington; C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB

## Abstract The original article to which this Erratum refers was published in Movement Disorders (2004) 19(11)1384–1385.

Reply: Botulinum type A therapy during p

Reply: Botulinum type A therapy during pregnancy

✍ David P. Charles; William J. Newman; Thomas L. Davis; Bimal B. Padaliya; Chandle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

We thank Drs. Bodkin, Maurer, and Wszolek 1 for their interest in our article on botulinum type A therapy during pregnancy, 2 which appeared in the November 2004 issue of Movement Disorders. The overall use of BOTOX for both treatment and cosmetic purposes continues to rise. Incidental exposures of

Botulinum toxin antibody type A titres a

Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy

✍ Dirk Dressler; Hans Bigalke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

Frey syndrome : Treatment with type A bo

Frey syndrome : Treatment with type A botulinum toxin

✍ Jens J. von Lindern; Bernd Niederhagen; Stefan Bergé; Georg Hägler; Rudolf H. Re 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB 👁 1 views

## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li

Long-term safety of botulinum toxin type

Long-term safety of botulinum toxin type A

✍ Markus Naumann; A. Peter Moore 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB